Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study

E. Messa, D. Gioia, E. Masiera, A. Castiglione, M. Ceccarelli, F. Salvi, P. Danise, A. Sanna, B. Allione, E. Balleari, A. Poloni, G. Cametti, D. Ferrero, R. Tassara, C. Finelli, M. Bonferroni, P. Musto, G. Saglio, A. Levis, V. Santini

Research output: Contribution to journalArticle

Cite this

Messa, E., Gioia, D., Masiera, E., Castiglione, A., Ceccarelli, M., Salvi, F., Danise, P., Sanna, A., Allione, B., Balleari, E., Poloni, A., Cametti, G., Ferrero, D., Tassara, R., Finelli, C., Bonferroni, M., Musto, P., Saglio, G., Levis, A., & Santini, V. (2019). Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study. Haematologica, 104(1), e4-e8. https://doi.org/10.3324/haematol.2017.183590